Abstract Search

ea0098c16 | Clinical – Chemo/SSA/Biologics | NANETS2023

Comparison of well-differentiated gastroenteropancreatic grade 3 neuroendocrine tumors (G3NETS): de novo and in the setting of apparent grade progression over time

Khuong Le Bryan , Paciorek Alan , Moon Farhana , Lawhn Heath Courtney , Hope Thomas , Fidelman Nicholas , Mulvey Claire , Lindsay Sheila , Zhang¬ Li , Nakakura Eric , Joseph Nancy , Bergsland Emily K.

Background: G3NETs demonstrate variable clinical behavior (Ki-67>20-100%). Treatment extrapolated from grade 1/2 (G1/2) NETs and neuroendocrine carcinomas depending on clinicopathologic features. Therapy for treatment-emergent G3NETs remains especially ill-defined.Methods: Retrospective chart review of patients with de novo G3NETs or progressing from low-to-high grade (L-H) (G1/2 at diagnosis and G3 >=3 months later). Treatment patterns compared ...

0 shares

ea0098c37 | Clinical – Nuclear Medicine/Interventional Radiology/Imaging | NANETS2023

Initial Experience Using 0.55T MRI for Detection of Liver Metastases in NET Patients

Remick Isabelle , Armstrong Hope Thomas , Ohliger Michael , William Hong Cheng , Yang Yang , Bergsland Emily , Lawhn Heath Courtney , Su Pan , Itriago-Leon Pedro

Background: 0.55T MRI is a new MRI technology offering increased patient accessibility with a wider bore (80cm) and reduced acoustic noise. We compared the sensitivity of liver metastases detection on gadoxetate-enhanced 0.55T MRI to 68Ga-DOTATATE PET/CT while evaluating patient experience.Methods: Nine patients with neuroendocrine liver metastases were imaged using gadoxetate-enhanced 0.55T MRI (MAGNETOM Free.Max, Siemens Healthineers, Erlang...

0 shares

Endocrine Abstracts

Comparison of well-differentiated gastroenteropancreatic grade 3 neuroendocrine tumors (G3NETS): de novo and in the setting of apparent grade progression over time

Initial Experience Using 0.55T MRI for Detection of Liver Metastases in NET Patients

BiosciAbstracts